Processa Pharmaceuticals Stock Price Patterns
| PCSA Stock | USD 2.44 0.19 7.22% |
Momentum 40
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.06) | EPS Estimate Current Year (10.75) | EPS Estimate Next Year (3.75) | Wall Street Target Price 25 | EPS Estimate Current Quarter (0.08) |
Using Processa Pharmaceuticals hype-based prediction, you can estimate the value of Processa Pharmaceuticals from the perspective of Processa Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Processa Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Processa because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Processa Pharmaceuticals after-hype prediction price | USD 2.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Processa Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Processa Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Processa Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Processa Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Processa Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Processa Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Processa Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Processa Pharmaceuticals' historical news coverage. Processa Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.13 and 21.54, respectively. We have considered Processa Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Processa Pharmaceuticals is very risky at this time. Analysis and calculation of next after-hype price of Processa Pharmaceuticals is based on 3 months time horizon.
Processa Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Processa Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Processa Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Processa Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.66 | 18.95 | 0.03 | 0.16 | 9 Events / Month | 6 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.44 | 2.61 | 0.76 |
|
Processa Pharmaceuticals Hype Timeline
Processa Pharmaceuticals is at this time traded for 2.44. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.16. Processa is projected to decline in value after the next headline, with the price expected to drop to 2.61. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.76%, whereas the daily expected return is at this time at -0.66%. The volatility of related hype on Processa Pharmaceuticals is about 8029.66%, with the expected price after the next announcement by competition of 2.28. The company has price-to-book ratio of 1.17. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Processa Pharmaceuticals recorded a loss per share of 28.75. The entity last dividend was issued on the 23rd of December 2019. The firm had 1:25 split on the 17th of December 2025. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Processa Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Processa Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Processa Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Processa Pharmaceuticals' future price movements. Getting to know how Processa Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Processa Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCTX | Briacell Therapeutics Corp | (0.80) | 7 per month | 0.00 | (0.08) | 13.96 | (9.09) | 98.43 | |
| CRIS | Curis Inc | (0.11) | 8 per month | 0.00 | (0.14) | 9.60 | (8.13) | 33.70 | |
| ENTO | Entero Therapeutics | (0.23) | 6 per month | 0.00 | (0.01) | 16.86 | (17.06) | 39.61 | |
| LPTX | Leap Therapeutics | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| PALI | Palisade Bio | (0.19) | 9 per month | 6.68 | 0.01 | 13.86 | (10.26) | 31.35 | |
| HOTH | Hoth Therapeutics | 0.01 | 7 per month | 0.00 | (0.21) | 4.81 | (5.79) | 14.85 | |
| MBRX | Moleculin Biotech | (0.50) | 9 per month | 0.00 | (0.21) | 9.37 | (11.73) | 41.63 | |
| ATHA | Athira Pharma | (0.54) | 8 per month | 4.13 | 0.05 | 6.70 | (8.06) | 71.83 | |
| ALLR | Allarity Therapeutics | (0.11) | 9 per month | 0.00 | (0.13) | 6.93 | (9.02) | 19.54 | |
| CTXR | Citius Pharmaceuticals | 0.1 | 9 per month | 0.00 | (0.14) | 10.59 | (9.49) | 38.23 |
Processa Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Processa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Processa using various technical indicators. When you analyze Processa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Processa Pharmaceuticals Predictive Indicators
The successful prediction of Processa Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Processa Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Processa Pharmaceuticals based on analysis of Processa Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Processa Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Processa Pharmaceuticals's related companies. | 2025 | 2026 (projected) | Payables Turnover | 3.16 | 3.32 | Days Of Inventory On Hand | 635.83 | 342.18 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |